Health IT Analytics March 10, 2021
A new sensor can monitor communications in the brain, speeding the development of Alzheimer’s precision medicine.
A newly-developed sensor can evaluate transmissions in the brain at both the microscopic and the nanoscopic level, accelerating Alzheimer’s precision medicine, according to a study published in Molecular Psychiatry.
The new method combines a biological sensor with two different forms of cutting-edge imaging. The approach can quantify neuromodulatory transmissions, which are associated with major brain disorders like Alzheimer’s, addiction, depressive disorders, and schizophrenia. These transmissions are also linked to autism, epilepsy, eating disorders, and sleep disorders.
Neuromodulatory transmissions are the slower transmissions in the brain, researchers noted. These transmissions are typically thought to involve a lot of neurons in large regions, as opposed to...
Today's Sponsors
Today's Sponsor